Article info
Recommendation
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management
- Correspondence to Marco Matucci-Cerinic, Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze 50139, Italy; marco.matuccicerinic{at}unifi.it
Citation
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management
Publication history
- Received March 24, 2020
- Revised April 15, 2020
- Accepted April 16, 2020
- First published April 29, 2020.
Online issue publication
May 20, 2020
Article Versions
- Previous version (29 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
This article is made freely available for use in accordance with BMJ"s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
https://bmj.com/coronavirus/usage